biologics
Angel Bio plans joint venture with Russian drugmaker
October 18, 2011Manufacturing and Production Angel Biotechnology, Materia Medica, Russia, biologics
UK contract manufacturing organisation Angel Biotechnology has agreed to set up a joint venture with Russian counterpart Materia Medica Holding …
Obama proposes seven year rule for biologics
September 21, 2011Research and Development, Sales and Marketing Obama, biologics
President Obama has returned to the issue of market exclusivity for biologic drugs as a way of cutting healthcare costs. …
Gilead buys manufacturing plant from Genentech
August 9, 2011Manufacturing and Production Genentech, Gilead, biologics
Roche unit Genentech has agreed to sell a clinical manufacturing plant in California to Gilead Sciences. The 70,000 sq. ft. …
BMS licences potential first-in-class cancer biologic
July 7, 2011Research and Development BMS, Cancer, biologics
Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …
Novo Nordisk invests €134m in Danish facility
June 24, 2011Manufacturing and Production Novo Nordisk, biologics, pharma manufacturing news
Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …
Bayer invests 35m euros in biologics production
December 14, 2010Manufacturing and Production Bayer, Germany, biologics, clinical trials supplies, pharma production
Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …
GSK paves way for biopharmaceuticals growth
September 9, 2010Research and Development GlaxoSmithKline, Lonza, biologics
GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …
Cancer Research UK facility celebrates first GMP batch
July 30, 2010Manufacturing and Production Biotherapeutic, Cancer Research UK, biologics
Cancer Research UK has produced the first batch of product from its recently-completed biologics manufacturing unit, and hopes to release …
Non-human sugars could compromise biologic drugs
July 28, 2010Manufacturing and Production biologicals, biologics, manufacturing
Many of the biologic drugs on the market today contain sugar molecule components that in some patients could undermine their …
MedImmune: building a biologics future
April 19, 2010Research and Development MedImmune, biologics
I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …
Sanofi refocuses its French manufacturing capacity
April 1, 2010Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics
Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …
UCB in ‘dynamic mode’ as work begins at new biologics research centre
July 31, 2009Research and Development UCB, biologics
UCB has opened its new biologics research centre in the UK, marking an investment of £25 million for the growing …
API market growth driven by biologics
May 13, 2009Manufacturing and Production biologics
The global market for active pharmaceutical ingredients is being transformed as big pharma companies devote more and more resources to …
Consortium wins US biodefence contract
April 3, 2009Manufacturing and Production biologics, vaccines
A consortium of US and UK companies has been awarded an $11 million grant from the US Government to speed …
Small and flexible: the manufacturing of tomorrow
March 24, 2009Manufacturing and Production biologics
Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's facilities facing dramatic …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
